Back to Search
Start Over
Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale
- Source :
- Diabetes Technology & Therapeutics. 22:216-221
- Publication Year :
- 2020
- Publisher :
- Mary Ann Liebert Inc, 2020.
-
Abstract
- Background: Continuous subcutaneous insulin infusion (CSII) is associated with improved glycemic control, a reduced incidence of hypoglycemia, and improved quality of life (QOL). To date, however, ...
- Subjects :
- Adult
Blood Glucose
Male
Pediatrics
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
030209 endocrinology & metabolism
Hypoglycemia
Infusions, Subcutaneous
03 medical and health sciences
Insulin Infusion Systems
0302 clinical medicine
Endocrinology
Quality of life
Surveys and Questionnaires
Diabetes mellitus
medicine
Humans
Hypoglycemic Agents
Insulin
030212 general & internal medicine
Glycemic
Glycated Hemoglobin
Psychiatric Status Rating Scales
Type 1 diabetes
business.industry
Incidence (epidemiology)
Reproducibility of Results
Middle Aged
medicine.disease
Subcutaneous insulin
Medical Laboratory Technology
Diabetes Mellitus, Type 1
Quality of Life
Female
business
Subjects
Details
- ISSN :
- 15578593 and 15209156
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Diabetes Technology & Therapeutics
- Accession number :
- edsair.doi.dedup.....cc78fde8509edb8345754b798b25b948